Bradley Bolzon, PhD

Brad Bolzon is a Managing Director who brings more than thirteen years of global pharmaceutical industry experience to Versant’s biotech investment team. He specializes in early-stage biotech investing with a particular emphasis on new company start-ups.

Prior to joining Versant, Brad served as Executive Vice President, Global Head of Business Development, Licensing & Alliances with F. Hoffmann-La Roche. Under his leadership, Roche established alliances with over 75 biotech companies worldwide and significantly strengthened its product pipeline. Previously, Brad held executive roles at Eli Lilly in drug discovery, clinical research, regulatory affairs, and business development.

Assistant

Sarah Cross

scross@versantventures.com

650-233-7447

Personal

Brad spends a great deal of time traveling for work and for pleasure. He lives part time in Basel, Switzerland and San Francisco and enjoys outdoor activities such as running, hiking and bike riding.